• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Executive Officer Glastra Matthijs converted options into 10,851 shares and covered exercise/tax liability with 5,247 shares, increasing direct ownership by 25% to 28,187 units (SEC Form 4)

    2/26/25 5:58:41 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous
    Get the next $NOVT alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Glastra Matthijs

    (Last) (First) (Middle)
    C/O NOVANTA INC.
    125 MIDDLESEX TURNPIKE

    (Street)
    BEDFORD MA 01730

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    NOVANTA INC [ NOVT ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    02/24/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 02/24/2025 M 10,851 A (1) 33,434 D
    Common Stock 02/24/2025 F 5,247 D $138.3 28,187 D
    Common Stock 41,487 I Anna Maria Vogelaar 2020 Trust
    Common Stock 54,382 I Matthijs Glastra 2021 Irrevocable Trust
    Common Stock 15,693 I Matthijs Glastra 2023 GRAT
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Performance Stock Units (1) 02/24/2025 M 10,851 (2) (2) Common Stock 10,851 (1) 10,852 D
    Explanation of Responses:
    1. Each Performance Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Performance Stock Unit.
    2. The number of shares underlying Performance Stock Unit award originally granted on February 24, 2021 became fixed upon ratification by the Compensation Committee of the Board of Directors based on 100% achievement of performance target, vesting as follows: 10,851 vested on February 24, 2025 and 10,852 will vest on February 24, 2026.
    Remarks:
    Power of Attorney on file
    /s/ John Burke, Attorney-in-Fact 02/26/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $NOVT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NOVT

    DatePrice TargetRatingAnalyst
    5/11/2022Mkt Perform → Outperform
    William Blair
    More analyst ratings

    $NOVT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Novanta to Present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025

      Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025, in White Plains, New York. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven a

      6/12/25 5:00:00 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous
    • Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025

      Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to

      5/15/25 5:00:00 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous
    • Novanta to Present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025

      Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025, in Chicago, IL. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to s

      5/13/25 5:00:00 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous

    $NOVT
    Leadership Updates

    Live Leadership Updates

    See more
    • IDEX Corporation Appoints Stephanie Disher and Matthijs Glastra to Board of Directors; David Parry and Livingston Satterthwaite to Retire

      IDEX Corporation (NYSE:IEX) today announced the appointment of Stephanie ("Steph") Disher and Matthijs Glastra to the company's Board of Directors. The appointments, effective Friday, February 21, 2025, increase the size of the Board from 10 to 12 directors. Ms. Disher will serve on the Board's Nominating and Corporate Governance Committee, and Mr. Glastra will serve on the Board's Audit Committee. Ms. Disher currently serves as Chief Executive Officer of Atmus Filtration Technologies Inc. (NYSE:ATMU), a leader in filtration and media solutions. She has extensive global leadership experience in finance and operations from her time at Atmus, Cummins Inc. and BP, p.l.c. Mr. Glastra currentl

      2/20/25 5:07:00 PM ET
      $ATMU
      $IEX
      $NOVT
      Auto Parts:O.E.M.
      Consumer Discretionary
      Fluid Controls
      Industrials
    • Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company's Full Potential

      Sends Letter to Masimo Shareholders and Releases 160-Page Investor Presentation Urges Shareholders to Help Deliver Immediate Change by Voting for Both of Politan's Independent and Ideally Qualified Nominees Darlene Solomon and William Jellison on the WHITE Card Shareholders Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI), today sent a letter to the Company's shareholders outlining why a majority of truly independent directors are urgently needed in the Masimo boardroom. Politan also released a detailed investor presentation m

      6/26/24 8:00:00 AM ET
      $A
      $ANIK
      $AVNT
      $MASI
      Biotechnology: Laboratory Analytical Instruments
      Industrials
      Medical/Dental Instruments
      Health Care

    $NOVT
    Financials

    Live finance-specific insights

    See more
    • Novanta Announces Financial Results for the First Quarter 2025

      First Quarter 2025 GAAP Revenue increased 1% to $233 million First Quarter 2025 GAAP Diluted Earnings Per Share of $0.59 and Adjusted EPS of $0.74 First Quarter 2025 GAAP Net Income increased 45% to $21 million First Quarter 2025 Adjusted EBITDA increased 1% to $50 million First Quarter 2025 Operating Cash Flow of $32 million Company reiterates Full Year 2025 Adjusted EBITDA guidance Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter 2025. Financial Highlights Three Months Ended   (In millions, except per share amoun

      5/6/25 7:00:00 AM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous
    • Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 6, 2025

      Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2025 results on Tuesday, May 6, 2025. The Company will host a conference call on Tuesday, May 6, 2025, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hours after the conclusion of the call on the E

      4/8/25 5:00:00 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous
    • Novanta Announces Financial Results for the Fourth Quarter and Full Year 2024

      Fourth Quarter 2024 GAAP Revenue increased 13% to $238 million, including $2 million unfavorable FX impact Fourth Quarter 2024 GAAP Diluted EPS of $0.46 and Adjusted EPS of $0.76 Full Year 2024 GAAP Revenue increased 8% to $949 million Full Year 2024 GAAP Diluted EPS of $1.77, and Adjusted EPS of $3.08 Full Year 2024 Adjusted EBITDA increased 7% to $210 million Full Year 2024 Operating Cash Flow increased 32% to $159 million Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2024. Financial Highlights

      2/25/25 7:00:00 AM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous